# RNN 2nd Gen Model Colgate-Palmolive Company Toilet preparations

Stock predictor AI models:
Subscribe >> Deal exit on
May 29, 2020
Deal entry on
May 29, 2020
8.37%Expected margin
81.97% successful of 61 deals
$ 72.33 Last close price
at 29-may-2020

CL

Model's trade recommendations No return for period yet

12.58% Annual return

$55.08B Market Cap

β 0.75  

CL

Model (following trade recommendations)

CL

Underlying stock

S&P 500

Index
Return for period
5.55%
1.78%
52wk return 15.54%
3.89%
16.82%
52wk Range
59.89—77.35
2000.54—2399.63
Sortino ratio 2.14
Sharpe ratio 1.42
Norm. RMSE 6.17%
Downside risk 5.56%
Volatility 0.00%
  • 1.68 (2.66%) Div (Yield)
  • HOLD Analysts consensus recommendation

Colgate-Palmolive is a leading global consumer products company, tightly focused on Oral Care, Personal Care, Home Care and Pet Nutrition. Colgate sells its products in over 200 countries and territories around the world under such internationally recognized brand names as Colgate, Palmolive, Softsoap, Irish Spring, Protex, Sorriso, Kolynos, elmex, Tom's of Maine, Sanex, Ajax, Axion, Soupline, and Suavitel, as well as Hill's Science Diet, Hill's Prescription Diet and Hill's Ideal Balance. As a leading consumer products company, they are also deeply committed to advancing technology that can address changing consumer needs throughout the world. In fact, their goal is to use technology to create products that will continue to improve the quality of life for consumers where they live.

Industry sector: Consumer Staples

Sector classification: Toilet preparations

Deep Learning based analysis and prediction model for Colgate-Palmolive Company (CL) stock is a 2nd Generation Non-linear Autoregressive (NAR) model based on the LSTM/GRU Recurrent Neural Network architecture.

Model is in the production pipeline since Oct. 2, 2015.

Market data for CL model training are being downloaded from the Quandl premium datasets on a daily basis.
Risks related to the novel coronavirus disease 2019 (COVID-19) caused by the virus named “SARS-CoV-2” are accounted for in this model in the form of the historical data coincided with outbreaks and other global events in the past used to train ML prediction model for CL.

Model is being retrained on a regular basis.

Float 863M
P/E 21.48
Shares Outstanding 872M
% Held by Insiders 1.02%
% Held by Institutions 73.68%
EPS (last reported FY) $2.87
EPS (last reported Q) $0.74
EPS, estimated (last reported Q) $0.73
Total revenues $15 B
Net income $2 B